The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression - Related Studies

The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression

This study has been completed.

Study NCT00035321. Last updated on July 21, 2006. Information provided by Eli Lilly and Company

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Major Depressive Disorder

2	Additional conditions recognized in this trial
		Depression
		Depressive Disorder
		Depressive Disorder, Major

3	More general conditions related to this trial
		Behavioral Symptoms
		Mental Disorders
		Mood Disorders

4	Interventions listed in this trial
		Olanzapine
		Fluoxetine

5	More general drug interventions related to this trial
		Antidepressive Agents
		Antidepressive Agents, Second-Generation
		Antiemetics
		Antipsychotic Agents
		Autonomic Agents
		Central Nervous System Agents
		Central Nervous System Depressants
		Gastrointestinal Agents
		Molecular Mechanisms of Pharmacological Action
		Neurotransmitter Agents
		Neurotransmitter Uptake Inhibitors
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Psychotropic Drugs
		Serotonin Agents
		Serotonin Uptake Inhibitors
		Therapeutic Uses
		Tranquilizing Agents

6	Sponsors listed in this trial
		Eli Lilly and Company